We are committed to stem the growing burden of cervical cancer among women in Asia

Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and most importantly, our patients remains as strong as it was on the first day of our journey. For further information, visit www.roche.com.

TogetHER for Health seeks to end cervical cancer deaths globally through advocacy, partnership, and knowledge-sharing, enabling equitable access to effective prevention and care. TogetHER works alongside global health leaders – including the American Cancer Society, Jhpiego, PATH, and Pathfinder International, among others – to put effective, equitable policies in place, to promote education and best clinical practices to improve cancer prevention globally, and to share stories of how cervical cancer affects women, their families, and their communities. TogetHER’s partners provide cervical cancer services in 31 countries and link thousands of girls and women with life-saving health services each year. For further information, visit www.togetherforhealth.org.

Jhpiego, a global health non-profit and Johns Hopkins University affiilate, creates and delivers transformative health care solutions that save lives. In partnership with national governments, health experts and local communities, Jhpiego builds health providers’ skills and develops systems that save lives now and guarantee healthier futures for women and their families. For further information, visit www.jhpiego.org.

The Cancer Awareness, Prevention and Early Detection (CAPED) Trust is a formidable community outreach organization that has been steadfastly dedicated to the healthcare domain since its inception in 2014. Focused on the critical areas of cancer prevention and early detection, CAPED has tirelessly worked towards transforming lives. Through impactful community outreach initiatives, relentless awareness campaigns, and facilitating accessible cancer screening for economically disadvantaged women, CAPED has left an indelible mark on society. With resounding success, we have already reached an astounding 47.5 million individuals through our awareness drives and conducted screenings for 31,711 individuals across 445 villages. Our unwavering commitment has garnered significant support from global organisations such as American Cancer Society (ACS), AstraZeneca, Roche Diagnostics and influential corporate entities such as Indraprastha Gas Limited, BMW Foundation, Birlasoft, Cvent, CAF, Safexpress, Tata 1mg, DSS, among others, reinforcing our cause. For more information, please visit our website at www.capedindia.org.

Global Initiative Against HPV and Cervical Cancer (GIAHC) is dedicated to ending HPV-related cancers, starting with cervical cancer. We operate both nationally and internationally, advocating for increased uptake of HPV vaccinations and promoting cervical screening through self-sampling and early treatment when necessary. Our signature programs include co-hosting the Us vs. HPV Prevention Week in collaboration with the American Medical Women’s Association (AMWA) and providing a platform for young leaders to champion this vital cause through the GIAHC Young Leaders program- as we believe it is their generation that will ultimately eliminate cervical cancer.